NCT06197009View on ClinicalTrials.gov

Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 1, 2026

Study Completion Date

August 1, 2026

Conditions
Axial Spondyloarthritis
Interventions
DRUG

SCT650C

Administered SC

Trial Locations (1)

06230

Hacettepe University Faculty of Medicine, Ankara

All Listed Sponsors
lead

Sinocelltech Ltd.

INDUSTRY